NEBL

Chr 10

nebulette

Also known as: C10orf113, LASP2, LNEBL, bA165O3.1

NEBL encodes nebulette, a protein that binds actin and plays an important role in Z-disk assembly and linking sarcomeric actin to desmin intermediate filaments in cardiac muscle. Mutations cause dilated cardiomyopathy with autosomal dominant inheritance. The gene shows tolerance to loss-of-function variants (LOEUF 1.139), suggesting the pathogenic variants may work through other mechanisms.

Summary from RefSeq, UniProt
Research Assistant →
0
Active trials
7
Pubs (1 yr)
2
P/LP submissions
P/LP missense
1.14
LOEUF
Multiple*
Mechanism· predicted
Clinical SummaryNEBL
🧬
Gene-Disease Validity (ClinGen)
dilated cardiomyopathy · ADLimited

Limited evidence — not for standalone diagnostic reporting

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
2 unique Pathogenic / Likely Pathogenic· 301 VUS of 500 total submissions
📖
GeneReview available — NEBL
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.14LOEUF
pLI 0.000
Z-score 0.63
OE 0.92 (0.741.14)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
-0.94Z-score
OE missense 1.11 (1.041.19)
606 obs / 544.3 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios
LoF OE0.92 (0.741.14)
00.351.4
Missense OE1.11 (1.041.19)
00.61.4
Synonymous OE1.12
01.21.6
LoF obs/exp: 58 / 63.4Missense obs/exp: 606 / 544.3Syn Z: -1.28
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
limitedNEBL-related dilated cardiomyopathyOTHERAD
DN
0.74top 25%
GOF
0.83top 10%
LOF
0.3259th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

500 submitted variants in ClinVar

Classification Summary

Pathogenic2
VUS301
Likely Benign176
Benign3
Conflicting1
2
Pathogenic
301
VUS
176
Likely Benign
3
Benign
1
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
2
0
2
Likely Pathogenic
0
0
0
0
0
VUS
19
263
18
1
301
Likely Benign
0
8
54
114
176
Benign
0
0
2
1
3
Conflicting
1
Total1927176116483

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

NEBL · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →